Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Laura M. Dember, MD

Laura M. Dember, MD Physician

Professor of Medicine at the Hospital of the University of Pennsylvania Professor of Epidemiology in Biostatistics and Epidemiology

Dr. Dember is employed by Penn Medicine.

About Dr. Laura M. Dember

Recognized by America's Top Doctors 2012 - 2018

Recognized by Best Doctors in America 2005-2011; 2013 - 2018

Recognized in Philadelphia magazine's annual Top Docs issues for 2018 and 2019

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Renal Electrolyte and Hypertension

Programs & Centers:

Board Certification:

  • Nephrology, 1994

Clinical Expertise:

  • Acute Interstitial Nephritis
  • Amyloid Nephropathy
  • Chronic Kidney Disease
  • Cryoglobulinemia
  • Diabetic Kidney Diseases
  • Dialysis
  • Dialysis Prevention
  • Dialysis Related Amyloidosis
  • Dietary Management of Chronic Kidney Disease
  • Elevated Creatinine
  • End-Stage Kidney Disease
  • Familial Renal Amyloidosis
  • Hemodialysis
  • Hypertension
  • Kidney Failure
  • Leg Swelling (Edema)
  • Light Chain Disorders
  • Medical Management of Chronic Kidney Disease
  • Myeloma Kidney
  • Nephrotic Syndrome
  • Peritoneal Dialysis
  • Proteinuria
  • Renal Insufficiency
  • Renal Replacement Therapy Education
  • Secondary Hyperparathyroidism
  • Uremia
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Yale University
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania
Fellowship: Brigham and Women's Hospital

Memberships

American College of Physicians, National American Society of Nephrology, National Chair, Data and Safety Monitoring Committee, Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease(TOP–CKD), NIDDK/NIH, National College of Physicians of Philadelphia, Local External Advisory Committee Member, Duke NIDDK O'Brien Kidney Center, National FDA-ASN Kidney Health Initiative, Core Committee Member, Clinical Trial Endpoints in Dialysis Vascular Access, National FDA-ASN Kidney Health Initiative, Workgroup Chair, Pragmatic Trials in Nephrology: Challenges and Opportunities, National Honorary Lifetime Member, Australia and New Zealand Society of Nephrology, International International Society of Nephrology, International Invited Member, Advancing Clinical Trials Key Issues in Trial Design Working Group, International Society of Nephrology, International Invited Participant, Controversies Conference on Blood Pressure and Volume Management in Dialysis; Kidney Disease:Improving Global Outcomes;, International Invited Participant, Duke Clinical Research Institute Think Tank: Accelerating Drug Development for Chronic Kidney Disease and End-Stage Renal Disease, Washington, DC, National Invited Participant, Kidney Disease: Improving Global Outcomes, Controversies Conference: "Challenges in the Conduct of Clinical Trials in Nephrology"; Paris, France, International Invited Participant/Panelist, Kidney Disease Clinical Trialists Workshop; Washington, DC, National Massachusetts Medical Society, Local Member, Data and Safety Monitoring Board, NIDDK Treatment of HIV Infection in Nigeria, NIDDK/NIH, National Member, External Advisory Board, O'Brien Kidney Center at Yale, National Member, International Society of Nephrology, International National Institute of Diabetes and Digestive and Kidney Diseases, NIH, National National Institutes of Diabetes and Digestive and Kidney Diseases, Chair, Forms Committee, Hemodialysis Novel Therapies Consortium, National National Institutes of Diabetes and Digestive and Kidney Diseases, Chair, Steering Committee, Time to Reduce Mortality in End-Stage Renal Disease Trial, National National Institutes of Diabetes and Digestive and Kidney Diseases, Member, Executive Committee, Hemodialysis Novel Therapies Consortium, National National Institutes of Diabetes and Digestive and Kidney Diseases, Member, Publications and Ancillary Studies Committee, Hemodialysis Fistula Maturation Consortium, National National Institutes of Diabetes and Digestive and Kidney Diseases, Member, Safety Committee, Hemodialysis Novel Therapies Consortium, National National Institutes of Diabetes and Digestive and Kidney Diseases, Member, Steering Committee, Hemodialysis Fistula Maturation Consortium, National National Kidney Foundation, National NIH Health Care Systems Research Collaboratory, Member, Health Care Systems Interactions Working Group, National

Hospital Affiliation

Dr. Dember is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Dr. Dember conducts patient-oriented research including mechanistic studies and clinical trials in chronic kidney disease and end-stage renal disease (ESRD). She has particular interests in hemodialysis vascular access and interventions to improve clinical outcomes in end-stage renal disease. Her research is funded by the National Institutes of Health. Dr. Dember is Principal Investigator for the Data Coordinating Center of the NIDDK Hemodialysis Novel Therapies Consortium which is conducting early phase clinical trials targeting ESRD-associated inflammation and cardiovascular disease, and she is the Principal Investigator for the "TiME Trial", a large, pragmatic cluster-randomized clinical trial being conducted through the NIH Health Care Systems Research Collaboratory. The TiME Trial has enrolled more than 7200 participants at 266 dialysis units throughout the United States and uses highly centralized implementation and data collection approaches that leverage the infrastructure and clinical care delivery systems of dialysis provider organizations. Dr. Dember is also a principal investigator for the NIDDK Hemodialysis Fistula Maturation Study -- a multicenter observational cohort study designed to elucidate predictors and mechanisms of arteriovenous fistula maturation, and she is a member of the Scientific and Data Coordinating Center for the NIDDK Chronic Renal Insufficiency Cohort Study.

Selected Publications:

Tong Xiaoyong, Hou Xiuyun, Wason Christopher, Kopel Tal, Cohen Richard A, Dember Laura M: Smooth Muscle Nitric Oxide Responsiveness and Clinical Maturation of Hemodialysis Arteriovenous Fistulae. Am J Pathol 187 (9): 2095-2101,2017.

Kopel Tal, Kaufman James S, Hamburg Naomi, Sampalis John S, Vita Joseph A, Dember Laura M: Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease. Clin J Am Soc Nephrol : 2017.

Alpers CE, Imrey PB, Hudkins KL, Wietecha TA, Radeva M, Allon M, Cheung AK, Dember LM, Roy-Chaudhury P, Shiu Y-T, Terry CM, Farber A, Beck GJ, Feldman HI, Kusek JW, Himmelfarb J.: Histopathology of veins at time of creation of arteriovenous fistulas: findings from the Hemodialysis Fistula Maturation Study J Am Soc Nephrol 28 (10): 3076-3088,2017.

Cheung AK, Imrey PB, Alpers CE, Robbin ML, Radeva M, Larive B, Shiu Y-T, Allon M, Dember LM, Greene T, Himmelfarb J, Roy-Chaudhury PR, Terry CM, Vazquez MA, Kusek JW, Feldman HI: Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study J Am Soc Nephrol 28 (10): 3005-3013,2017.

Courtright KR, Madden V, Gabler NB, Cooney E, Kim J, Herbst N, Burgoon L, Whealdon J, Dember LM, Halpern SD: A randomized trial of expanding choice sets to motivate advance directive completion Med Decis Making : 2016 .

Sawinski Deirdre, Lim Mary Ann, Cohen Jordana C, Locke Jayme E, Weiss Brendan, Hogan Jonathan J, Dember Laura M: Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis. Transplantation 102 (2): 300-309,2018.

Dember LM, Archdeacon P, Krishnan M, Lacson E, Ling SM, Roy-Chaudhury P, Smith KA, Flessner MF: Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative. J Am Soc Nephrol 27 (10): 2955-2963,2016.

Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR, Martin KJ, McNei JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI, Dialysis Access Consortium (DAC) Study Group: Effect of dipyridamole plus aspirin on hemodialysis graft patency N Engl J Med 360 : 2191-2201,2009.

Dember LM, Beck GJ, Allon M, Delmez J, Dixon BS, Greenberg A, Himmelfarb J, Vazquez VA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI. Dialysis Access Consortium (DAC) Study Group: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized, controlled trial JAMA 299 : 2164-71,2008.

Dember LM, Hawkins PN, Hazenberg BPC, Gorevic PD, Merlini G, Butriemene I, Livneh A, Lesnyak O, puechal X, Lachmann H, Obici L, Balshaw R, Garceau D, Hauck W. Skinner M: Eprodisate for the treatment of renal disease in AA amyloidosis N Engl J Med 356 : 2349-60,2007.

Academic Contact Info

Renal-Electrolyte and Hypertension Division
University of Pennsylvania Perelman School of Medicine
Center for Clinical Epidemiology and Biostatistics
Blockley Hall, Office 920
423 Guardian Drive

Philadelphia, PA 19104
Phone: (215) 573-5264
Patient appointments: 800-789-7366 (PENN)